HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changzhen Liu Selected Research

Bone Resorption

11/2021Vaccine of RANKL mutant conjugated with KLH effectively stabilizing bone metabolism and preventing trabecular microstructural degeneration in osteoporotic rats.
6/2010Structural and functional insights of RANKL-RANK interaction and signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Changzhen Liu Research Topics

Disease

8Neoplasms (Cancer)
02/2020 - 01/2013
3Melanoma (Melanoma, Malignant)
01/2014 - 01/2013
2Osteoporosis
11/2021 - 09/2015
2Bone Resorption
11/2021 - 06/2010
1Fatty Liver
01/2024
1Insulin Resistance
01/2024
1Obesity
01/2024
1Non-alcoholic Fatty Liver Disease
01/2024
1Low Back Pain (Lumbago)
08/2023
1Postoperative Hemorrhage
08/2023
1Pathologic Constriction (Stenosis)
08/2023
1Hematoma
08/2023
1Pain (Aches)
08/2023
1Spondylolisthesis
08/2023
1COVID-19
05/2023
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Metabolic Bone Diseases (Osteopenia)
06/2017
1Immune System Diseases (Immune Disorders)
09/2015
1Colorectal Neoplasms (Colorectal Cancer)
12/2014
1Breast Neoplasms (Breast Cancer)
12/2014
1Communicable Diseases (Infectious Diseases)
01/2013
1Infections
01/2013
1Rabies (Hydrophobia)
01/2013
1Vascular Diseases (Vascular Disease)
07/2009

Drug/Important Bio-Agent (IBA)

3Monoclonal AntibodiesIBA
11/2021 - 12/2014
3LigandsIBA
06/2017 - 07/2009
3AntigensIBA
01/2014 - 01/2013
2VaccinesIBA
11/2021 - 09/2015
2AntibodiesIBA
11/2021 - 09/2015
2CytokinesIBA
11/2015 - 09/2015
2GPA 7IBA
01/2014 - 11/2013
2HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2014 - 11/2013
2Single-Domain AntibodiesIBA
11/2013 - 01/2013
1celastrolIBA
01/2024
1Glucose (Dextrose)FDA LinkGeneric
01/2024
1LipidsIBA
01/2024
1Oleic Acid (Oleate)IBA
01/2024
1Disinfectants (Biocides)IBA
05/2023
1AerosolsIBA
05/2023
1RANK LigandIBA
11/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2020
1Interleukin-2 (IL2)IBA
05/2016
1ErbB Receptors (EGF Receptor)IBA
11/2015
1LuciferasesIBA
12/2014
1Neoplasm Antigens (Tumor Antigens)IBA
01/2014
1Chimeric Antigen ReceptorsIBA
01/2014
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2013
1Neutralizing AntibodiesIBA
01/2013
1Immunoglobulins (Immunoglobulin)IBA
01/2013
1OsteoprotegerinIBA
06/2010
1NF-kappa B (NF-kB)IBA
06/2010
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
07/2009

Therapy/Procedure

6Immunotherapy
05/2016 - 01/2013
4Therapeutics
01/2020 - 01/2013
1Length of Stay
08/2023
1Conservative Treatment
08/2023
1Decompression
08/2023
1Endoscopes
08/2023
1Ovariectomy (Oophorectomy)
11/2021
1Subcutaneous Injections
11/2021
1Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2020
1Radiotherapy
01/2020